Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1113/week)
    • Manufacturing(556/week)
    • Technology(1109/week)
    • Energy(420/week)
    • Utilities(299/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Thalassemia

Nov 05, 2018
Global Thalassemia Market and Competitive Landscape to 2023 - Track Market Size, Competitor Drug Sales & Market Shares
Sep 12, 2018
Global Thalassemia Drugs Market 2018-2022
Sep 11, 2018
Global Thalassemia Drugs Market 2018-2022 with ApoPharma, Fresenius Kabi, Novartis, Pfizer & Teva Pharmaceutical Industries Dominating
Sep 06, 2018
Protagonist Therapeutics Receives $1.45 Million SBIR Funding for the Development of PTG-300
Aug 21, 2018
Adult Hemoglobinopathy Testing Market is Projected to Grow at a CAGR of 3.9% by 2026 - Persistence Market Research
Jun 20, 2018
Thalassemia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Jun 18, 2018
Protagonist Announces Phase 1 and Pre-clinical Data on Hepcidin Mimetic PTG-300 Presented at European Hematology Association Annual Meeting
May 31, 2018
Thalassemia Treatment Market to Collect US$ 1,639.6 Mn by 2026, Says TMR
May 17, 2018
Protagonist Therapeutics Announces Two Oral Presentations Accepted for 23rd Congress of the European Hematology Association
Apr 12, 2018
Thalassemia Market Size Worth $3.53 Billion by 2022 | CAGR: 10.8%: Grand View Research, Inc.
Mar 06, 2018
FDA Grants Orphan Drug Designation for Protagonist Therapeutics' PTG-300 for the Treatment of Beta-Thalassemia
Dec 14, 2017
Protagonist Therapeutics Announces Final Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300
Dec 09, 2017
Bioengineering and Specialized Therapies Yield Results for Rare and Challenging Blood Diseases
Oct 02, 2017
Sangamo And Bioverativ Announce FDA Acceptance Of IND Application For ST-400 -- A Gene-Edited Cell Therapy Candidate -- To Treat Beta-Thalassemia
Sep 20, 2017
Protagonist Therapeutics Announces Preliminary Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300
Aug 28, 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
Jun 23, 2017
European Hematology Association: Treating Sickle Cell Disease and Beta-Thalassemia with CRISPR/Cas9 Gene Editing
Jun 08, 2017
Canadian Scientists Honored for Role in Breakthrough Drug
Jun 05, 2017
Cooley's Anemia Foundation to Honor Scientists for Role in Breakthrough Drug
  • ‹‹
  • Page 2
  •  

Latest News

Sep 8, 2025

Community Celebrates Grand Opening of Landmark at Dublin with Ribbon Cutting Ceremony

Sep 7, 2025

Winning the battle with mold--advice from Central Coast Casualty & Restoration

Sep 7, 2025

GTB Technologies® to Present AI-Ready Compliance and Data Security Solutions at the Gartner Enterprise Risk,...

Sep 7, 2025

HYPERSHELL UNVEILS X ULTRA: THE WORLD'S BEST OUTDOOR EXOSKELETON, REDEFINING HUMAN ADVENTURE AND...

Sep 7, 2025

IDEAYA Biosciences and Hengrui Pharma Present Positive Phase 1 Data for IDE849 (SHR-4849), a Potential First-...

Sep 7, 2025

BLUETTI at IFA Berlin 2025: Empowering a Greener Tomorrow with Clean Energy

Sep 7, 2025

BLUETTI Unveils Pioneer Na, RVSolar System and FridgePower at IFA 2025

Sep 7, 2025

StratX Launches Compliance-Aware Routing Protocol for Stablecoins, RWAs, and Cross-Border Settlement

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia